GBCS / Selectis Health, Inc. - SEC फाइलिंग, वार्षिक रिपोर्ट, प्रॉक्सी स्टेटमेंट

सेलेक्टिस हेल्थ, इंक.
US ˙ OTCPK

मूलभूत आँकड़े
CIK 727346
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Selectis Health, Inc.
SEC Filings (Chronological Order)
यह पृष्ठ SEC फाइलिंग की एक पूरी, कालानुक्रमिक सूची प्रदान करता है, ओनरशिप फाइलिंग को छोड़कर, जो हम अन्यत्र प्रदान करते हैं।
August 14, 2025 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT UNDER SECTION 13 OR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 Selectis Health, Inc. (Exact name of Registr

July 16, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 13, 2025 SELECTIS HEALTH, IN

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 13, 2025 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Numbe

June 20, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 20, 2025 SELECTIS HEALTH, IN

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 20, 2025 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Numbe

May 21, 2025 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT UNDER SECTION 13 O

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 Selectis Health, Inc. (Exact name of Regist

May 15, 2025 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 816291108 NOTICE OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 11-K ☐ Form 20-F ☒ Form 10-Q ☐ Form N-SAR For Period Ended: March 31, 2025 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part I—Reg

April 15, 2025 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-15415 Selectis Health, Inc. (Exact name of Regist

March 31, 2025 NT 10-K

U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25

U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 816291108 NOTICE OF LATE FILING (Check One): ☒ Form 10-K ☐ Form 11-K ☐ Form 20-F ☐ Form 10-Q ☐ Form N-SAR For Period Ended: December 31, 2024 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part I—Registran

February 13, 2025 EX-10.2

Purchase and Sale Agreement – Sparta Facility

Exhibit 10.2 PURCHASE AND SALE AGREEMENT by and between Providence HR, LLC (“Seller”), and Sparta Propco Holdco LLC (“Purchaser”) February 7, 2025 PURCHASE AND SALE AGREEMENT This PURCHASE AND SALE AGREEMENT (this “Agreement”), dated effective as of February 7, 2025 (the “Effective Date”), is by and between Providence HR, LLC, a Georgia limited liability company (“Seller”), and Sparta Propco Holdc

February 13, 2025 EX-10.1

Purchase and Sale Agreement – Glen Eagle, Eastman and Warrenton Facilities

Exhibit 10.1 PURCHASE AND SALE AGREEMENT by and between Global Abbeville Property, LLC Dodge NH, LLC Atl/Warr, LLC (collectively, “Seller”), and Abbeville Propco Holdco LLC (“Purchaser”) February 7, 2025 PURCHASE AND SALE AGREEMENT This PURCHASE AND SALE AGREEMENT (this “Agreement”), dated effective as of February 7, 2025 (the “Effective Date”), is by and between Global Abbeville Property, LLC, Do

February 13, 2025 EX-10.3

Operations Transfer Agreement -Glen Eagle, Eastman and Warrenton Facilities

Exhibit 10.3 OPERATIONS TRANSFER AGREEMENT THIS OPERATIONS TRANSFER AGREEMENT (“Agreement”) made effective as of February 7, 2025 (the “Effective Date”) is entered into by and among Global Abbeville, LLC, Global Eastman, LLC, and Selectis Warrenton, LLC, each a Georgia limited liability company (collectively, the “Existing Operator” or “Operator”) and Abbeville Opco Holdco LLC, a Delaware limited

February 13, 2025 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 7, 2025 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Nu

February 13, 2025 EX-10.5

Escrow Agreement

Exhibit 10.5 DEPOSIT ESCROW AGREEMENT THIS DEPOSIT ESCROW AGREEMENT dated February 7, 2025 is made by and among Global Abbeville Property, LLC, Dodge NH, LLC and Atl/Warr, LLC, each a Georgia limited liability company (individually and collectively, “Seller”), Abbeville Propco Holdco LLC, a Delaware limited liability company (individually and collectively, “Purchaser”), and Landmark Abstract Agenc

February 13, 2025 EX-10.4

Operations Transfer Agreement – Sparta Facility

Exhibit 10.4 OPERATIONS TRANSFER AGREEMENT THIS OPERATIONS TRANSFER AGREEMENT (“Agreement”) made effective as of February 7, 2025 (the “Effective Date”) is entered into by and among Selectis Sparta, LLC, a Georgia limited liability company (the “Existing Operator” or “Operator”) and Sparta Opco Holdco LLC, a Delaware limited liability company (the “New Operator” and together with the Existing Oper

January 23, 2025 EX-10.1

Separation Agreement and Release

Exhibit 10.1

January 23, 2025 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 17, 2025 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Nu

December 9, 2024 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 4, 2024 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Nu

November 22, 2024 EX-16.1

Pursuant to Item 304(a)(1) of Regulation S-K, the Registrant herewith files the letter of Marcum LLP, former accountants to the Company.

Exhibit 16.1

November 22, 2024 8-K

Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 20, 2024. SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction Commission File (I.R.S. Employer o

November 14, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT UNDER SECTION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 Selectis Health, Inc. (Exact name of Re

October 4, 2024 10-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A-1 ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT UNDER SECTION 13 OR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A-1 ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-15415 Selectis Health, Inc. (Exact name of Re

October 4, 2024 CORRESP

8480 E. Orchard Rd, Ste 4900 Greenwood Village, CO 80111

8480 E. Orchard Rd, Ste 4900 Greenwood Village, CO 80111 Via Edgar Filing October 4, 2024 Kellie Kim Division of Corporation Finance US Securities and Exchange Commission Washington, DC Re: Selectis Health, Inc. Form 10-K for the year ended December 31,2023 Filed April 16, 2024 File No. 000-15415 Ladies and Gentlemen: Please accept the following in response to the comments of the Commission dated

October 1, 2024 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 1, 2024 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Num

August 29, 2024 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 27, 2024 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Num

August 29, 2024 EX-10.1

Offer Letter

Exhibit 10.1

August 16, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT UNDER SECTION 13 OR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 Selectis Health, Inc. (Exact name of Registr

August 15, 2024 NT 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25/A-1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25/A-1 SEC File Number 0-15415 CUSIP Number 816291108 NOTICE OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 11-K ☐ Form 20-F ☒ Form 10-Q ☐ Form N-SAR For Period Ended: June 30, 2024 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part I—

August 14, 2024 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 816291108 NOTICE OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 11-K ☐ Form 20-F ☒ Form 10-Q ☐ Form N-SAR For Period Ended: June 30, 2024 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part I—Regi

July 11, 2024 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2024 SELECTIS HEALTH, IN

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2024 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Numbe

June 25, 2024 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 18, 2024 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Numbe

May 15, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT UNDER SECTION 13 O

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 Selectis Health, Inc. (Exact name of Regist

May 9, 2024 EX-99.1

- Archway Nursing Facility and Related Property to be Sold for $6.75 Million -

Exhibit 99.1 Selectis Health Enters Definitive Purchase and Sale Agreement for Archway Transitional Care Center in Georgia - Archway Nursing Facility and Related Property to be Sold for $6.75 Million - Greenwood Village, Colorado, May 9, 2024 – Selectis Health, Inc. (OTC: GBCS) (“Selectis” or the “Company”) announced that its wholly-owned subsidiary, Goodwill Hunting, LLC (the “Seller”), has execu

May 9, 2024 8-K

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2024 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Number

May 8, 2024 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2024 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Number

May 8, 2024 EX-10.1

Purchase and Sale Agreement

Exhibits 10.1

April 23, 2024 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 12, 2024 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Numb

April 23, 2024 EX-10.1

Commercial Line of Credit Agreement and Note

Exhibit 10.1

April 16, 2024 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-15415 Selectis Health, Inc. (Exact name of Regist

April 1, 2024 NT 10-K

U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25

U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 816291108 NOTICE OF LATE FILING (Check One): ☒ Form 10-K ☐ Form 11-K ☐ Form 20-F ☐ Form 10-Q ☐ Form N-SAR For Period Ended: December 31, 2023 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part I—Registran

March 25, 2024 EX-10.1

Indemnity Agreement

Exhibit 10.1 INDEMNITY AGREEMENT This Indemnity Agreement (this “Agreement”), dated as of , 202, is made by and between SELECTIS HEALTH, INC., a Utah corporation (the “Company”), and, a director and/or officer of the Company (the “Indemnitee”). RECITALS A. The Company is aware that competent and experienced persons are increasingly reluctant to serve as directors or officers of corporations unless

March 25, 2024 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2024 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Numb

March 25, 2024 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2024 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Numb

February 22, 2024 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 20, 2024 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File N

December 22, 2023 8-K

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 18, 2023 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File N

December 22, 2023 EX-99.1

Jim Creamer Appointed as Interim Chief Financial Officer Clifford Neuman Appointed to Board of Directors

Exhibit 99.1 Selectis Health Makes Key Leadership Appointments Jim Creamer Appointed as Interim Chief Financial Officer Clifford Neuman Appointed to Board of Directors Greenwood Village, CO – December 19, 2023 – Selectis Health, Inc. (OTC: GBCS) (“Selectis” or the “Company”) has appointed Jim Creamer as Interim Chief Financial Officer and Clifford Neuman to its board of directors. Creamer’s appoin

December 5, 2023 8-K

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 30, 2023 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File N

December 5, 2023 EX-10.2

Operations Transfer Agreement

Exhibit 10.2 EXECUTION COUNTERPART OPERATIONS TRANSFER AGREEMENT THIS OPERATIONS TRANSFER AGREEMENT (“Agreement”) dated as of November 30, 2023 (the “Effective Date”) is by and Global Abbeville, LLC, a Georgia limited liability company, Global Eastman, LLC, a Georgia limited liability company, Selectis Sparta, LLC, a Georgia limited liability company, and Selectis Warrenton, LLC, a Georgia limited

December 5, 2023 EX-99.1

Selectis Health Enters Agreements to Sell Four Skilled Nursing Facilities in Georgia - The Company’s Warrenton, Eastman, Glen Eagle, and Sparta Facilities to be Acquired for an Aggregate Consideration of $31 Million -

Exhibit 99.1 Selectis Health Enters Agreements to Sell Four Skilled Nursing Facilities in Georgia - The Company’s Warrenton, Eastman, Glen Eagle, and Sparta Facilities to be Acquired for an Aggregate Consideration of $31 Million - Greenwood Village, Colorado, December 5, 2023 – Selectis Health, Inc. (OTC: GBCS) (“Selectis” or the “Company”) announced that several wholly owned affiliates (the “Affi

December 5, 2023 EX-10.1

Purchase and Sale Agreement

Exhibit 10.1 Execution Counterpart PURCHASE AND SALE AGREEMENT by and between Global Abbeville Property, LLC Dodge NH, LLC Providence HR, LLC Atl/Warr, LLC (collectively, “Seller”), and Glen Eagle Propco LLC Eastman Propco LLC Providence Propco LLC Warrenton Propco LLC (collectively “Purchaser”) November 30, 2023 PURCHASE AND SALE AGREEMENT This PURCHASE AND SALE AGREEMENT (this “Agreement”), date

November 13, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT UNDER SECTION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 Selectis Health, Inc. (Exact name of Re

November 6, 2023 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 31, 2023 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Nu

September 21, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT UNDER SECTION 13 OR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 Selectis Health, Inc. (Exact name of Registr

August 8, 2023 NT 10-Q

U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25

U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 816291108 NOTICE OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 11-K ☐ Form 20-F ☒ Form 10-Q ☐ Form N-SAR For Period Ended: June 30, 2023 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part I—Registrant In

August 8, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT UNDER SECTION 13 O

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 Selectis Health, Inc. (Exact name of Regist

June 30, 2023 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-15415 Selectis Health, Inc. (Exact name of Regist

May 31, 2023 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 31, 2023 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Number

May 16, 2023 NT 10-Q

U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25

U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 816291108 NOTICE OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 11-K ☐ Form 20-F ☒ Form 10-Q ☐ Form N-SAR For Period Ended: March 31, 2023 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part I—Registrant I

March 31, 2023 NT 10-K

U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25

U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 816291108 NOTICE OF LATE FILING (Check One): ☒ Form 10-K ☐ Form 11-K ☐ Form 20-F ☐ Form 10-Q ☐ Form N-SAR For Period Ended: December 31, 2022 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part I—Registran

March 13, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 6, 2023 SELECTIS HEALTH, IN

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 6, 2023 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Numbe

January 6, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ☐ TRANSITION REPORT UNDER SECTION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 Selectis Health, Inc. (Exact name of Re

December 8, 2022 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 7, 2022 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Nu

November 16, 2022 8-K

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2022 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File N

November 16, 2022 EX-99.1

November 2022 Investor Presentation.

Exhibit 99.1

November 14, 2022 NT 10-Q

U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25

NT 10-Q 1 formnt10-q.htm U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 816291108 NOTICE OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 11-K ☐ Form 20-F ☒ Form 10-Q ☐ Form N-SAR For Period Ended: September 30, 2022 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification rel

October 31, 2022 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 31, 2022 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Nu

October 26, 2022 8-K

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 25, 2022 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission FileNum

October 26, 2022 EX-99.1

October, 2022 Investor Presentation.

Exhibit 99.1

October 20, 2022 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

DEF 14A 1 formdef14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule

October 20, 2022 EX-99.1

- Company Concurrently Announces Resignation of Clifford Neuman as Director and Secretary - - Sink’s Appointment as Independent Director Fulfills Remaining Corporate Governance Requirements for Major National Exchange Listing -

Exhibit 99.1 Selectis Health Appoints Andrew Sink to Board of Directors - Company Concurrently Announces Resignation of Clifford Neuman as Director and Secretary - - Sink?s Appointment as Independent Director Fulfills Remaining Corporate Governance Requirements for Major National Exchange Listing - Greenwood Village, CO ? October 18, 2022 ? Selectis Health, Inc. (OTC: GBCS) (?Selectis? or the ?Com

October 20, 2022 8-K

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 18, 2022 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction Commission (I.R.S. Employer of incor

October 18, 2022 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 17, 2022 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Nu

October 5, 2022 EX-16.1

Pursuant to Item 304(a)(1) of Regulation S-K, the Registrant herewith files the letter of Haynie & Company, former accountants to the Company.

Exhibit 16.1

October 5, 2022 8-K

Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 4, 2022 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction Commission File (I.R.S. Employer of i

September 20, 2022 8-K

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 20, 2022 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File

September 20, 2022 EX-99.1

Selectis Health Reports First Half 2022 Results and Provides Business Update - First Quarter and Second Quarter 10-Q Filings Allow the Company to Regain Compliance with SEC Reporting Obligations - - Q2 2022 Revenue Increases 91% Year-over-Year to a R

Exhibit 99.1 Selectis Health Reports First Half 2022 Results and Provides Business Update - First Quarter and Second Quarter 10-Q Filings Allow the Company to Regain Compliance with SEC Reporting Obligations - - Q2 2022 Revenue Increases 91% Year-over-Year to a Record $11.5 Million - - Q2 2022 Net Income Increases Significantly to Over $1.0 Million - Greenwood Village, Colorado, September 19, 2022

September 19, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ☐ TRANSITION REPORT UNDER SECTION 13 O

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 Selectis Health, Inc. (Exact name of Regist

September 19, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ☐ TRANSITION REPORT UNDER SECTION 13 OR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 Selectis Health, Inc. (Exact name of Registr

August 26, 2022 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-15415 Selectis Health, Inc. (Exact name of Regist

August 18, 2022 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 18, 2022 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Num

July 29, 2022 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 25, 2022 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Numbe

July 29, 2022 EX-10.6

Whistleblower Policy

Exhibit 10.6 SELECTIS HEALTH, INC. Whistleblower Policy Procedures for the Submission of Complaints or Concerns regarding Financial Statement or other Disclosures, Accounting, Internal Accounting or Disclosure Controls, Auditing Matters or violations of the Selectis Health, Inc. Code of Business Conduct and Ethics. Section 301 of the Sarbanes-Oxley Act requires the Audit Committee of the Board of

July 29, 2022 EX-10.2

Nominating and Governance Committee Charter

Exhibit 10.2 SELECTIS HEALTH, INC. NOMINATING AND GOVERNANCE COMMITTEE CHARTER As adopted by the Nominating and Governance Committee and Board of Directors on July 25, 2022 I. PURPOSE The primary purpose of the Nominating and Governance Committee (the ?Committee?) of the Board of Directors (the ?Board?) of Selectis Health, Inc., (the ?Company?) shall be to act on behalf of the Board in fulfilling

July 29, 2022 EX-10.1

Audit Committee Charter

Exhibit 10.1 SELECTIS HEALTH, INC. AUDIT COMMITTEE CHARTER As adopted by the Audit Committee and Board of Directors on July 25, 2022 I. RESPONSIBILITY The Selectis Health, Inc.?s (?Selectis?) Audit Committee (?Committee?) was established to assist the Board of Directors (the ?Board?) in carrying out its oversight compliance with laws responsibilities that relate to Selectis? accounting and financi

July 29, 2022 EX-10.4

Code of Conduct and Ethics Policy

Exhibit 10.4 SELECTIS HEALTH, INC. CODE OF BUSINESS CONDUCT AND ETHICS Adopted as of July 25, 2022 Introduction This Code of Business Conduct and Ethics (the ?Code?) applies to Selectis Health, Inc. (?Selectis? or the ?Company?). This Code covers a wide range of business practices and procedures. The Code should also be provided to and followed by the Company?s agents and representatives, includin

July 29, 2022 EX-10.5

Document Retention Policy

Exhibit 10.5 SELECTIS HEALTH, INC. DOCUMENT RETENTION POLICY The corporate records of Selectis Health, Inc., a Delaware corporation (hereafter the ?Company?) are important assets. Corporate records include essentially all records you produce as an employee, whether paper or electronic. A record may be as obvious as a memorandum, an e-mail, a contract or a case study, or something not as obvious, s

July 29, 2022 EX-10.3

Compensation Committee Charter

Exhibit 10.3 SELECTIS HEALTH, INC. COMPENSATION COMMITTEE CHARTER As adopted by the Compensation Committee and Board of Directors on July 25, 2022 Purpose The Compensation Committee (the ?Committee?) exists to assist the Board of Directors in the discharge of its fiduciary responsibilities relating to the fair and competitive compensation of the executives and other key employees of the Company. T

July 5, 2022 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 1, 2022 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Number

May 17, 2022 NT 10-Q

U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25

NT 10-Q 1 formnt10-q.htm U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 816291108 NOTICE OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 11-K ☐ Form 20-F ☒ Form 10-Q ☐ Form N-SAR For Period Ended: March 31, 2022 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates

April 4, 2022 EX-10.2

Non-Statutory Stock Option Agreement- Barker

Exhibit 10.2 SELECTIS HEALTH, INC. NON-STATUTORY STOCK OPTION AGREEMENT This Non-Statutory Stock Option Agreement (the ?Agreement?) is made and entered into effective the 30th day of March, 2022, between Selectis Health, Inc. (the ?Company?) and Christopher Barker (?Optionee?). NOW, THEREFORE, it is hereby agreed as follows: 1. Grant of Option. The Company hereby grants to Optionee, as of the date

April 4, 2022 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 30, 2022 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Numb

April 4, 2022 EX-10.1

Non-Statutory Stock Option Agreement - Baller

Exhibit 10.1 SELECTIS HEALTH, INC. NON-STATUTORY STOCK OPTION AGREEMENT This Non-Statutory Stock Option Agreement (the ?Agreement?) is made and entered into effective the 30th day of March, 2022, between Selectis Health, Inc. (the ?Company?) and Lance Baller (?Optionee?). NOW, THEREFORE, it is hereby agreed as follows: 1. Grant of Option. The Company hereby grants to Optionee, as of the date hereo

March 29, 2022 NT 10-K

U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25

NT 10-K 1 formnt10-k.htm U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 816291108 NOTICE OF LATE FILING (Check One): ☒ Form 10-K ☐ Form 11-K ☐ Form 20-F ☐ Form 10-Q ☐ Form N-SAR For Period Ended: December 31, 2021 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification rela

March 9, 2022 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 4, 2022 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Numbe

January 28, 2022 EX-16.1

Pursuant to Item 304(a)(1) of Regulation S-K, the Registrant herewith files the letter of MaloneBailey, LLP, former accountants to the Company

Exhibit 16.1

January 28, 2022 8-K

Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 26, 2022 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Nu

January 21, 2022 8-K/A

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A-1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 6, 2022 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File

January 12, 2022 8-K

Unregistered Sales of Equity Securities, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 6, 2022 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Num

January 12, 2022 EX-99.1

Financial Public Investor Relations Agreement

Exhibit 99.1

January 10, 2022 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 6, 2022 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Num

January 3, 2022 8-K/A

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A-1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 29, 2021 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission Fi

January 3, 2022 EX-4.4

Rescission Agreement

Exhibit 4.4

December 30, 2021 EX-4.3

Barker Restricted Stock Unit

Exhibit 4.3

December 30, 2021 EX-4.1

Deferred Compensation and Equity Award Plan

Exhibit 4.1 SELECTIS HEALTH, INC. DEFERRED COMPENSATION AND EQUITY AWARD PLAN Effective on July 1, 2021 1. Purpose. (a) Selectis Health, Inc. (?Selectis?) has established this Deferred Compensation and Equity Award Plan (the ?Plan? ). (b) The purpose of the Plan is to enable officers, directors and key employees (?Eligible Persons?) to defer receipt of compensation for their services on behalf of

December 30, 2021 EX-4.2

Baller Restricted Stock Unit

Exhibit 4.2

December 30, 2021 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 29, 2021 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File N

November 17, 2021 8-K

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 16, 2021 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File N

November 17, 2021 EX-99.1

SUMMARY OF THIRD QUARTER RESULTS SELECTIS HEALTH, INC. CONSOLIDATED BALANCE SHEETS

Exhibit 99.1 Selectis Health Reports Third Quarter 2021 Financial Results Greenwood Village, Colorado, November 16, 2021 ? Selectis Health, Inc. (OTC: GBCS) (?Selectis? or the ?Company?) today reported a Net Loss for the three months ended September 30, 2021, of $0.06 million, or a net loss of $0.02 per diluted share. Total revenue increased to $7.32 million for the third quarter of 2021 compared

November 15, 2021 8-K

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 12, 2021 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File N

November 15, 2021 EX-99.1

Exhinit 99.1

Exhinit 99.1 Selectis Health Schedules Third Quarter Earnings Call for Tuesday, November 16, 2021 Greenwood Village, Colorado, November 12, 2021 ? Selectis Health, Inc. (OTC: GBCS) (?Selectis? or the ?Company?), announced today that it expects to issue its third quarter 2021 financial results on November 16, 2021. Conference Call Selectis invites current and prospective investors to join the share

November 15, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION REPORT UNDER SECTION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 Selectis Health, Inc. (Exact name of Re

November 4, 2021 EX-99.1

November, 2021 Investor Presentation.

Exhibit 99.1

November 4, 2021 8-K

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 3, 2021 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission FileNum

October 4, 2021 EX-10.2

Healthcare Facility Note

Exhibit 10.2

October 4, 2021 EX-99.1

Selectis Health Announces Refinance, Renovation, and new Executive Director of Southern Hills Campus

Exhibit 99.1 Selectis Health Announces Refinance, Renovation, and new Executive Director of Southern Hills Campus GREENWOOD VILLAGE, Colorado, September 28, 2021 ? Selectis Health, Inc. (the ?Company? or ?Selectis?), (OTC: GBCSD) announced today that it successfully refinanced the mortgage on the Southern Hills Continuing Care Retirement Community (?CCRC?) after completing several renovations, and

October 4, 2021 8-K

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 27, 2021 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File

October 4, 2021 EX-10.1

Healthcare Mortgage, Assignment of Leases and Rents and Security Agreement

Exhibit 10.1

September 22, 2021 8-K

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 21, 2021 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File

September 22, 2021 EX-10.1

Amendment No. 1 to Second Amended and Restated Articles of Incorporation

Exhibit 10.1 AMENDMENT NO. 1 TO SECOND AMENDMENT AND RESTATED ARTICLES OF INCORPORATION OF SELECTIS HEALTH, INC. (formerly Global Healthcare REIT, Inc.) Pursuant to the Utah Business Corporation Act, (the ?Act?) the undersigned being the President and Secretary of Selectis Health, Inc., formerly Global Healthcare REIT, Inc. (the ?Company? or the ?Corporation?) hereby affirm that the following Amen

September 22, 2021 EX-99.1

Selectis Health Announces Effective Date of Reverse Stock Split and Name Change

Exhibit 99.1 Selectis Health Announces Effective Date of Reverse Stock Split and Name Change Common Stock Will Begin Trading with its new name and on a Split-Adjusted Basis on September 22, 2021 GREENWOOD VILLAGE, Colorado, September 21, 2021 ? Selectis Health, Inc. (formerly Global Healthcare REIT, Inc.) (the ?Company? or ?Selectis?), announced today that it intends to effect a reverse stock spli

September 9, 2021 SC 13D/A

GBCS / Global Healthcare REIT Inc / Baller Lance Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D/A-4 Under the Securities Exchange Act of 1934 (Amendment No. 4)* SELECTIS HEALTH, INC., f/k/a GLOBAL HEALTHCARE REIT, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 37953J 10 7 (CUSIP Number) Clifford L. Neuman, PC 6800 N. 79th Street, Suite 200 Niwot, Colorado 80503 (303) 449 – 2100 (Name, Addr

August 16, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ☐ TRANSITION REPORT UNDER SECTION 13 OR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 SELECTIS HEALTH, INC. f/k/a GLOBAL HEALTHCAR

July 14, 2021 8-K

Unregistered Sales of Equity Securities

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 9, 2021 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Number

June 21, 2021 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 18, 2021 SELECTIS HEALTH, INC. f/k/a Global Healthcare REIT, Inc. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of i

May 26, 2021 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 24, 2021 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File

May 26, 2021 EX-99.1

SUMMARY OF FIRST QUARTER RESULTS GLOBAL HEALTHCARE REIT, INC. CONSOLIDATED BALANCE SHEETS ( UN AUDITED)

Exhibit 99.1 Updated: Selectis Health Reports First Quarter 2021 Financial Results Greenwood Village, Colorado, May 20, 2021 (GLOBE NEWSWIRE) ? Global Healthcare REIT, Inc. (Currently in a rebranding effort to Selectis Health, Inc.) (OTC: GBCS) (?Selectis? or the ?Company?) today reported net income for the first quarter of 2021 of $240,566, or $0.01 per diluted share. Total revenue increased 49.6

May 26, 2021 8-K

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 20, 2021 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File

May 20, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 [ ] TRANSITION REPORT UNDER SECTION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 GLOBAL HEALTHCARE REIT, INC. (Exact nam

May 17, 2021 NT 10-Q

U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25

U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 37953J107 NOTICE OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 11-K [ ] Form 20-F [ x ] Form 10-Q [ ] Form N-SAR For Period Ended: March 31, 2021 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part I?

April 9, 2021 8-K

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 2, 2021 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction Commission (I.R.S. Employer of i

April 9, 2021 EX-99.1

SUMMARY OF FOURTH QUARTER AND YEARD-END 2020 RESULTS GLOBAL HEALTHCARE REIT, INC. CONSOLIDATED BALANCE SHEETS (AUDITED)

Exhibit 99.1 Selectis Health Reports Fourth Quarter and Year-End 2020 Financial Results Greenwood Village, Colorado, March. 31, 2021 – Global Healthcare REIT, Inc. (Currently in a rebranding effort to Selectis Health, Inc.) (OTC: GBCS) ("Selectis" or the "Company") today reported net income for the fourth quarter of 2020 of $1.3 million, or $0.05 per diluted share, and $2.93 million, or $.11 per d

April 9, 2021 DEF 14A

-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) [X] Def

March 31, 2021 8-K/A

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported):March 30, 2021 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction Commission (I.R.S. Employer of

March 31, 2021 EX-99.1

Conference Details

Exhibit 99.1 Selectis Health Announces the Reopening of Renovated Oklahoma City Facility and 2020 Financial Results Conference Call Greenwood Village, Colorado, March 30, 2021 – Global Healthcare REIT, Inc. (Currently in a rebranding effort to Selectis Health, Inc.) (OTC: GBCS) (“Selectis” or the “Company”) is pleased to announce that it was granted its Nursing Facility License by the Oklahoma Sta

March 31, 2021 10-K

Annual Report -

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-15415 GLOBAL HEALTHCARE REIT, INC. (Exact nam

March 30, 2021 EX-99.1

Conference Details

EX-99.1 2 ex99-1.htm Exhibit 99.1 Selectis Health Announces the Reopening of Renovated Oklahoma City Facility and 2020 Financial Results Conference Call Greenwood Village, Colorado, March 30, 2021 – Global Healthcare REIT, Inc. (Currently in a rebranding effort to Selectis Health, Inc.) (OTC: GBCS) (“Selectis” or the “Company”) is pleased to announce that it was granted its Nursing Facility Licens

March 30, 2021 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 1, 2021 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction Commission (I.R.S. Employer of

March 9, 2021 PRE 14A

-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [X] Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Def

January 28, 2021 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 27, 2021 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission

January 6, 2021 EX-99.1

Selectis Health Announces the Completion of Oklahoma Fairlands Skilled Nursing Facility Purchase

Exhibit 99.1 Selectis Health Announces the Completion of Oklahoma Fairlands Skilled Nursing Facility Purchase Niwot, Colorado., January 4, 2021 – Global Healthcare REIT, Inc. (Currently in a rebranding effort to Selectis Health, Inc.) (OTC: GBCS) (“Selectis” or the “Company”) is pleased to announce that, through its newly formed wholly-owned subsidiary Global Fairland Property, LLC (“Fairland Prop

January 6, 2021 EX-10.2

EX-10.2

Exhibit 10.2

January 6, 2021 8-K

Regulation FD Disclosure, 8-K, 8-K, 8-K, 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 31, 2020 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission

January 6, 2021 EX-10.1

Promissory Note

EX-10.1 2 ex10-1.htm Exhibit 10.1

January 6, 2021 8-K

-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 5, 2021 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission F

January 5, 2021 EX-99.1

Selectis Health Appoints President and Chief Operating Officer

EX-99.1 2 ex99-1.htm Exhibit 99.1 Selectis Health Appoints President and Chief Operating Officer Greenwood Village, Colorado, January 5, 2021 (GLOBE NEWSWIRE) —Global Healthcare REIT, Inc. (Currently in a rebranding effort to be renamed Selectis Health, Inc.) (OTC: GBCS) (“Selectis” or the “Company”) an owner and operator of healthcare facilities in AR, GA, OH, and OK today announced that Randy Ba

January 5, 2021 8-K

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 1, 2021 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission F

December 31, 2020 10-Q

Quarterly Report -

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 GLOBAL HEALTHCARE REIT, INC. (Exact

December 2, 2020 8-K

-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 30, 2020 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission

November 19, 2020 8-K

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 19, 2020 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission

November 19, 2020 EX-99.1

GLOBAL HEALTHCARE REIT, INC. CONSOLIDATED BALANCE SHEETS

Exhibit 99.1 Global Healthcare Announces 2nd Quarter 2020 Results Niwot, Colorado., Nov. 19 , 2020 ? Global Healthcare REIT, Inc. (OTC: GBCS) (?Global? or the ?Company?) announced financial results for the second quarter ended June 30, 2020. SECOND QUARTER 2020 HIGHLIGHTS ? Record revenue for the second quarter of $5,130,465 (2019 $1,614,424) a growth rate of 217% year-over -year and up 33% from t

November 18, 2020 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 [ ] TRANSITION REPORT UNDER SECTION 1

10-Q 1 form10-q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 GLOBAL HEALTHCARE RE

October 14, 2020 10-Q

Quarterly Report -

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 GLOBAL HEALTHCARE REIT, INC. (Exact nam

October 1, 2020 8-K

-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 29, 2020 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commissio

August 24, 2020 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 18, 2020 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission F

August 14, 2020 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2020 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission Fi

July 27, 2020 EX-10.1

Asset Purchase Agreement

Exhibit 10.1 ASSET PURCHASE AGREEMENT by and between TG OPERATIONS, LLC An Oklahoma Limited Liability Company as Seller, and GLOBAL FAIRLAND PROPERTY, LLC, An Oklahoma Limited Liability Company, as Purchaser July 23, 2020 TABLE OF CONTENTS PAGE 1. PURCHASE AND SALE 1 2. TRANSFER OF OPERATIONS. 2 3. THE PROPERTY. 2 4. EXCLUDED PROPERTY 2 5. CLOSING 2 6. PURCHASE PRICE. 3 7. EXPENSES. 3 8. PRORATION

July 27, 2020 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 23, 2020 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission Fil

July 10, 2020 10-K

Annual Report -

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-15415 GLOBAL HEALTHCARE REIT, INC . (Exact na

May 18, 2020 8-K/A

-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 12, 2020 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission Fi

May 13, 2020 8-K

-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 12, 2020 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File

May 13, 2020 NT 10-K

-

U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 37953J107 NOTICE OF LATE FILING (Check One): [X] Form 10-K [ ] Form 11-K [ ] Form 20-F [ ] Form 10-Q [ ] Form N-SAR For Period Ended: December 31, 2019 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part I

May 7, 2020 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2020 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File

April 28, 2020 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 20, 2020 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission Fi

March 30, 2020 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 27, 2020 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission Fi

March 5, 2020 EX-10.2

Form of Senior Note

EX-10.2 3 ex10-2.htm Exhibit 10.2

March 5, 2020 EX-10.6

Form of Corporate Guaranty

Exhibit 10.6

March 5, 2020 EX-10.5

Form of Seller Note

EX-10.5 6 ex10-5.htm Exhibit 10.5

March 5, 2020 8-K

8-K, 8-K, 8-K, 8-K

8-K 1 form8-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 2, 2020 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporati

March 5, 2020 EX-10.4

Form of Security Agreement

Exhibit 10.4

March 5, 2020 EX-10.3

Form of Mortgage, Security Agreement and Assignment of Rents

EX-10.3 4 ex10-3.htm Exhibit 10.3

March 5, 2020 EX-10.1

Asset Purchase Agreement

Exhibit 10.1

February 4, 2020 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 17, 2020 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission

December 3, 2019 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 21, 2019 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission

November 19, 2019 EX-99.1

November 2019 Investor Presentation

November 19, 2019 8-K

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 19, 2019 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission

November 18, 2019 10-Q

GBCS / Global Healthcare REIT, Inc. 10-Q - Quarterly Report -

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 GLOBAL HEALTHCARE REIT, INC. (Exact

November 15, 2019 NT 10-Q

GBCS / Global Healthcare REIT, Inc. NT 10-Q - -

U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 37953J107 NOTICE OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 11-K [ ] Form 20-F [x] Form 10-Q [ ] Form N-CEN For Period Ended: September 30, 2019 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part

November 15, 2019 SC 13D/A

GBCS / Global Healthcare REIT, Inc. / Rhine Zvi Michael Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D/A-1 Under the Securities Exchange Act of 1934 (Amendment No. 1)* GLOBAL HEALTHCARE REIT, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 37953J 10 7 (CUSIP Number) Clifford L. Neuman, PC 6800 N. 79th Street, Suite 200 Niwot, Colorado 80503 (303) 449 – 2100 (Name, Address, and Telephone Number of

October 23, 2019 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 16, 2019 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission

September 24, 2019 8-K

Current Report

8-K 1 form8-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 24, 2019 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorp

August 19, 2019 10-Q

GBCS / Global Healthcare REIT, Inc. 10-Q - Quarterly Report -

10-Q 1 form10-q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 GLOBAL HEALTHCARE RE

August 14, 2019 NT 10-Q

GBCS / Global Healthcare REIT, Inc. NT 10-Q - -

NT 10-Q 1 formnt10-q.htm U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 37953J107 NOTICE OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 11-K [ ] Form 20-F [x] Form 10-Q [ ] Form N-CEN For Period Ended: June 30, 2019 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notificatio

August 13, 2019 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2019 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission Fi

August 13, 2019 EX-10.1

Loan Document Purchase and Assignment Agreement

EX-10.1 2 ex10-1.htm LOAN DOCUMENT PURCHASE AND ASSIGNMENT AGREEMENT THIS LOAN DOCUMENT PURCHASE AND ASSIGNMENT AGREEMENT (the “Agreement”), is effective this 26th day of July, 2019 (the “Effective Date”), by and between F&M BANK (“Assignor” or “Seller”) and GLOBAL HEALTHCARE REIT, INC., a Utah corporation (“Assignee” or “Buyer”). RECITALS A. Assignor is a party to certain loan documents which evi

July 11, 2019 EX-10.1

Healthcare Facility Note

EX-10.1 2 ex10-1.htm

July 11, 2019 8-K

Current Report

8-K 1 form8-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 13, 2019 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporati

June 5, 2019 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2019 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File

May 20, 2019 10-Q

GBCS / Global Healthcare REIT, Inc. 10-Q - Quarterly Report -

10-Q 1 form10-q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 GLOBAL HEALTHCARE R

May 15, 2019 NT 10-Q

GBCS / Global Healthcare REIT, Inc. NT 10-Q

U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 37953J107 NOTICE OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 11-K [ ] Form 20-F [x] Form 10-Q [ ] Form N-SAR For Period Ended: March 31, 2019 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part I—Re

April 17, 2019 8-K

Unregistered Sales of Equity Securities

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 15, 2019 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission Fi

April 17, 2019 EX-10.1

Amendment No. 1 to Employment Agreement

AMENDMENT NO. I TO EMPLOYMENT AGREEMENT This Amendment No. I to Employment Agreement dated May 4, 2018 is made and entered into effective the 1st day of April, 2019 by and between Global Healthcare REIT, Inc. (the “Company”) and Zvi Rhine (“Employee”). RECITALS A. Employee and the Company entered into an Employment Agreement dated May 4, 2018, to be effective January 1, 2018 (the “Employment Agree

April 16, 2019 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 12, 2019 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission Fi

April 16, 2019 EX-10.1

Asset Purchase Agreement

EX-10.1 2 ex10-1.htm

April 16, 2019 10-K

GBCS / Global Healthcare REIT, Inc. (Annual Report)

10-K 1 form10-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-15415 GLOBAL HEALTHCARE R

April 1, 2019 NT 10-K

GBCS / Global Healthcare REIT, Inc.

U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 37953J107 NOTICE OF LATE FILING (Check One): [X] Form 10-K [ ] Form 11-K [ ] Form 20-F [ ] Form 10-Q [ ] Form N-SAR For Period Ended: December 31, 2018 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part

March 7, 2019 SC 13D/A

GBCS / Global Healthcare REIT, Inc. / Baller Lance Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D/A-3 Under the Securities Exchange Act of 1934 (Amendment No. 3)* GLOBAL HEALTHCARE REIT, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 37953J 10 7 (CUSIP Number) Clifford L. Neuman, PC 6800 N. 79th Street, Suite 200 Niwot, Colorado 80503 (303) 449 – 2100 (Name, Address, and Telephone Number of

February 26, 2019 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 25, 2019 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission

December 4, 2018 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 4, 2018 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission

November 19, 2018 10-Q

GBCS / Global Healthcare REIT, Inc. 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 OR [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 GLOBAL HEALTHCARE REIT, INC. (Exact

November 13, 2018 NT 10-Q

GBCS / Global Healthcare REIT, Inc. NT 10-Q

U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 37953J107 NOTICE OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 11-K [ ] Form 20-F [ x ] Form 10-Q [ ] Form N-SAR For Period Ended: September 30, 2018 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Par

November 8, 2018 8-K

Current Report

8-K 1 form8-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2018 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorpor

October 22, 2018 EX-99.1

Form of Note

October 22, 2018 8-K

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

8-K 1 form8-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 15, 2018 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction Commission

October 10, 2018 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 1, 2018 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission F

September 14, 2018 SC 13D/A

GBCS / Global Healthcare REIT, Inc. / Baller Lance Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION SCHEDULE 13D/A-2 Under the Securities Exchange Act of 1934 (Amendment No.

August 27, 2018 8-K

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 27, 2018 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission F

August 27, 2018 EX-99.1

Revised 2018 Investor Presentation

August 13, 2018 8-K

Current Report

8-K 1 form8-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 3, 2018 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporat

August 13, 2018 10-Q

GBCS / Global Healthcare REIT, Inc. 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 OR [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 GLOBAL HEALTHCARE REIT, INC. (Exact name

June 27, 2018 10-Q

GBCS / Global Healthcare REIT, Inc. 10-Q (Quarterly Report)

10-Q 1 form10-q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 OR [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 GLOBAL HEALTHCARE R

May 15, 2018 NT 10-Q

GBCS / Global Healthcare REIT, Inc. NT 10-Q

U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 37953J107 NOTICE OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 11-K [ ] Form 20-F [x] Form 10-Q [ ] Form N-SAR For Period Ended: March 31, 2018 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part I—Re

May 10, 2018 EX-10.2

Notice of Grant

GLOBAL HEALTHCARE REIT, INC. NOTICE OF GRANT OF STOCK OPTION Notice is hereby given of the following option grant (the “Option”) to purchase shares of the Common Stock of Global Healthcare REIT, Inc., a Utah corporation (the “Company”): OPTIONEE: ZVI RHINE GRANT DATE: APRIL 1 2018, VESTING COMMENCEMENT DATE: APRIL 1, 2018 EXERCISE PRICE: $0.36 PER SHARE NUMBER OF OPTION SHARES: 600,000 SHARES OF C

May 10, 2018 EX-10.1

Restricted Stock Award Agreement

AGREEMENT FOR RESTRICTED STOCK AWARD THIS AGREEMENT FOR RESTRICTED STOCK AWARD is made and entered into effective 1st day of April, 2018, by and between GLOBAL HEALTHCARE REIT, INC.

May 10, 2018 EX-10.3

Option Agreement

GLOBAL HEALTHCARE REIT, INC. NON-QUALIFIED STOCK OPTION AGREEMENT This Non-Qualified Stock Option Agreement (the “Agreement”) is attached as Exhibit A to a Notice of Grant of Stock Option (the “Grant Notice”), pursuant to which Optionee has been informed of the basic terms of the option evidenced thereby. Certain capitalized terms used but not otherwise defined herein have the respective meanings

May 10, 2018 8-K

Unregistered Sales of Equity Securities

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2018 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File

May 10, 2018 EX-10.4

Employment Agreement

EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (“Agreement”) made and entered into this 1st day of April, 2018, to be effective as of the 1st day of January, 2018 (the “Effective Date”), by and between GLOBAL HEALTHCARE REIT, a Utah corporation (the “Company”) and ZVI RHINE (the “Executive”).

May 10, 2018 SC 13D

GBCS / Global Healthcare REIT, Inc. / Rhine Zvi Michael Activist Investment

SC 13D 1 formsc13d.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* GLOBAL HEALTHCARE REIT, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 37953J 10 7 (CUSIP Number) Clifford L. Neuman, PC 6800 N. 79th Street, Suite 200 Niwot, Colorado 80503 (303) 449 – 2100 (Name, Address, and Tele

April 24, 2018 8-K

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 24, 2018 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission Fi

April 24, 2018 EX-99.1

2018 Investor Presentation

April 24, 2018 10-K

GBCS / Global Healthcare REIT, Inc. 10-K (Annual Report)

10-K 1 form10-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-15415 GLOBAL HEALTHCARE R

April 17, 2018 EX-10.1

Purchase and Sale Agreement

PURCHASE AND SALE AGREEMENT THIS PURCHASE AND SALE AGREEMENT (this “Agreement”) is made by and between MIDWAY NIMITZ, LLC, a Georgia limited liability company (“Purchaser”) and GORDON JENSEN HEALTH CARE ASSOCIATION, INC.

April 17, 2018 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 5, 2018 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission Fil

March 29, 2018 NT 10-K

GBCS / Global Healthcare REIT, Inc. NT 10-K

U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 37953J107 NOTICE OF LATE FILING (Check One): [ X ] Form 10-K [ ] Form 11-K [ ] Form 20-F [ ] Form 10-Q [ ] Form N-SAR For Period Ended: December 31, 2017 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part

January 23, 2018 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 23, 2018 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission

January 23, 2018 SC 13D/A

GBCS / Global Healthcare REIT, Inc. / Park City Capital, LLC - SC 13D/A Activist Investment

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) Under the Securities Exchange Act of 1934 (Amendment No.

November 20, 2017 10-Q

GBCS / Global Healthcare REIT, Inc. 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 OR [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission file number 0-15415 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Sm

November 16, 2017 EX-99.1

SERIES 2017 10% SENIOR PROMISSORY NOTE DUE OCTOBER 31, 2020

EX-99.1 3 ex99-1.htm THIS NOTE HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN

November 16, 2017 EX-10.1

Form of Agreement Among Lenders

AGREEMENT BY AND AMONG LENDERS This Agreement is made and entered into as of the day of , 2017, by and between Global Healthcare REIT, Inc.

November 16, 2017 8-K

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2017 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction Commission (I.R.S. Employer o

November 14, 2017 NT 10-Q

GBCS / Global Healthcare REIT, Inc. 0-Q

U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 37953J107 NOTICE OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 11-K [ ] Form 20-F [x] Form 10-Q [ ] Form N-SAR For Period Ended: September 30, 2017 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part

November 6, 2017 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 27, 2017 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction Commission (I.R.S. Employer o

November 6, 2017 EX-10.2

Meadowview Note – High Street Nursing, LLC

November 6, 2017 EX-10.1

HUD Note – Providence HR, LLC

EX-10.1 2 ex10-1.htm

November 6, 2017 EX-10.3

Credit Note – Southern Tulsa, LLC and Southern Tulsa TLC, LLC

EX-10.3 4 ex10-3.htm

October 17, 2017 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 16, 2017 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission

September 11, 2017 SC 13D/A

GBCS / Global Healthcare REIT, Inc. / Baller Lance Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION SCHEDULE 13D/A-1 Under the Securities Exchange Act of 1934 (Amendment No.

August 21, 2017 10-Q

GBCS / Global Healthcare REIT, Inc. 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 OR [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission file number 0-15415 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Small B

August 14, 2017 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 2, 2017 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission Fi

August 14, 2017 NT 10-Q

Global Healthcare REIT 0-Q

U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 37953J107 NOTICE OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 11-K [ ] Form 20-F [x] Form 10-Q [ ] Form N-SAR For Period Ended: June 30, 2017 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part I?Reg

June 14, 2017 10-Q

GBCS / Global Healthcare REIT, Inc. 10-Q (Quarterly Report)

10-Q 1 form10-q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [ X ] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 OR [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission file number 0-15415 GLOBAL HEALTHCARE REIT, INC.

May 16, 2017 8-K

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2017 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction Commission File (I.R.S. Employer

May 16, 2017 EX-99.1

Revised 2017 Investor Presentation

May 15, 2017 NT 10-Q

Global Healthcare REIT 0-Q

U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 37953J107 NOTICE OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 11-K [ ] Form 20-F [x] Form 10-Q [ ] Form N-SAR For Period Ended: March 31, 2017 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part I?Re

May 5, 2017 EX-10.1

Allonge and Modification Agreement

ALLONGE AND MODIFICATION AGREEMENT This ALLONGE AND MODIFICATION AGREEMENT (“Modification”) is entered into this 3rd day of May, 2017, by and between the undersigned (“Lender”); and GOODWILL HUNTING, LLC, a Georgia limited liability company (“Borrower”); RECITALS A.

May 5, 2017 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2017 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction Commission (I.R.S. Employer of inc

April 28, 2017 10-K

Global Healthcare REIT (Annual Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-15415 GLOBAL HEALTHCARE REIT, INC . (Exact na

April 7, 2017 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 4, 2017 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission Fil

March 31, 2017 8-K/A

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A-1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 30, 2017 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commissio

March 21, 2017 NT 10-K

Global Healthcare REIT 0-K

U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 37953J107 NOTICE OF LATE FILING (Check One): [X] Form 10-K [ ] Form 11-K [ ] Form 20-F [ ] Form 10-Q [ ] Form N-SAR For Period Ended: December 31, 2016 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part I

March 15, 2017 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 14, 2017 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission Fi

January 30, 2017 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 30, 2017 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction Commission (I.R.S. Employer o

January 26, 2017 8-K

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 25, 2017 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista